An Enhanced Medication Monitoring Program

MedMinder Systems

Status and phase: Unknown; Phase 1

Conditions: Hypertension; Medication Adherence

Treatments: Device: MedMinder System - deactivated; Device: MedMinder System

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01105104

1R43HL097395-01A1

Details and patient eligibility

About

The goal of the Enhanced Medication Management Program (eMMp) being developed by MedMinder Systems, Inc. is to increase the ability of frail elders to adhere to complex medication regimens for chronic conditions. Adherence will facilitate effective self-care and decrease personal and societal costs associated with disease progression and loss of independence. Multiple studies have shown that more frequent personal follow-up is the most effective way to maximize medication adherence, but such personal care is too costly to translate well to real life in a world of limited healthcare resources.

Currently available "smart pillboxes" are too expensive, too limited in the number and types of medications delivered, and too technically complex for the large majority of senior citizens. The eMMp is designed to deliver prompts and reminders to the user, to be remotely programmable by caregivers, to allow the option of using pre-filled medication trays, to provide electronic adherence reports to family/caregivers and to provide personalized reinforcing phone calls from professional caregivers, all at a modest cost. The in-home ReMinder will use a familiar pillbox layout (4 doses/day for 7 days) and allow easy removal of medication cups by elderly, rheumatic fingers. Installation will require only an electrical outlet (no modems or dedicated phone lines). Once plugged in, the built-in pager will continuously download remotely programmed visual and/or aural prompts and reminders from a central server (RemoteMind). It will continuously upload the date and time when each medi-cation cup is removed and when weekly refill is carried out, enabling remote adherence monitoring, alerts to caregivers, and follow-up intervention(s) from personal and/or professional caregivers as needed.

The hypothesis to be tested in this 2 year SBIR Phase I work plan is that the eMMp will significantly im-prove adherence and clinical outcome (blood pressure control) in a population of frail elderly who are hyper-tensive. SBIR Phase II will determine the minimum level of intervention needed to achieve sustained medication adherence and control of blood pressure in a larger group of hypertensive elders.

Enrollment: 150 estimated patients

Sex: All

Ages: 55+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• persons aged 55 years and older who are coming in for routine outpatient visits
• speaks and reads English
• history of high blood pressure
• systolic blood pressure ≥ 130 mm Hg
• using antihypertensive medication
• using 2 or more prescription medications
• plans to stay in area for the 9 months of study

Exclusion criteria

• receives personal help or reminders to take medication
• has moderate to severe dementia (MMSE score<18)
• has severe hearing or vision deficiency

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

150 participants in 2 patient groups

MedMinder System

Other group

Treatment:

Device: MedMinder System

MedMinder System - deactivated

Other group

Treatment:

Device: MedMinder System - deactivated